Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological conditions.
Hansa scientists are working on developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy, as well as exploring the potential application of the technology platform in oncology.
Company Details
- Employees
- 151
- Founded
- -
- Address
- Scheelevägen 22, Lund,223 63,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hansamedical.com
- Keywords
- Biopharmaceuticals, Clinical development, Drug discovery, In vitro diagnostics, Kidney transplantation, Autoimmune disease, Sepsis, Antibody glycosylation, Orphan drug, Immunomodulatory, Rare diseases.
- HQ
- Lund
Hansa Biopharma Questions
Hansa Biopharma's website is hansamedical.com
Hansa Biopharma's LinkedIn profile is https://se.linkedin.com/company/hansa-medical-ab
Hansa Biopharma has
151 employees.
View email and phone details for 151
employees at Hansa Biopharma.
Hansa Biopharma's industry is
Biotechnology Research
Hansa Biopharma's top competitors are
Immunovia Ab,
Camurus,
Galenica Ab,
Rechon Life Science Ab,
Alligator Bioscience Ab,
Genovis,
Svar Life Science Ab,
Polypeptide Group,
Bioglan Ab,
Bioinvent International Ab.
Hansa Biopharma's categories are Biotechnology Research
Hansa Biopharma's founding year is 2007
